Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

24.22
Delayed Data
As of Jun 18
 +0.46 / +1.94%
Today’s Change
10.85
Today|||52-Week Range
33.82
+27.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash598.5M679.2M963.0M1.4B
 
 
 
 
 
Short Term Investment Cash-311.6M87.6M289.6M463.6M
 
 
 
 
 
Cash & Short Term Investments615.4M704.2M994.0M1.4B
 
 
 
 
 
 
ReceivablesReceivables7.3B7.4B7.1B6.3B
 
 
 
 
 
 
InventoriesInventories5.1B5.1B4.9B5.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses870.2M1.2B1.1B1.1B
 
 
 
 
 
Other Current Assets655.4M1.8B1.2B714.0M
 
 
 
 
 
Current Assets14.6B16.2B15.4B14.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross12.2B12.4B12.2B12.1B
 
 
 
 
 
Depreciation-4.2B-4.4B-4.5B-4.7B
 
 
 
 
 
Intangible Assets61.6B60.2B46.1B45.8B
 
 
 
 
 
Other Assets62.8B61.2B46.9B46.6B
 
 
 
 
 
Total Assets86.3B86.0B70.6B69.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable2.3B2.4B2.1B1.9B
 
 
 
 
 
Short Term Debt1.2B2.7B3.6B1.3B
 
 
 
 
 
Accrued Expenses2.8B2.6B3.0B2.6B
 
 
 
 
 
Other Current Liabilities11.2B11.1B11.7B10.9B
 
 
 
 
 
Other Liabilities15.4B16.9B17.9B14.8B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt33.8B31.9B28.8B29.4B
 
 
 
 
 
Deferred Taxes-4.7B-4.4B-2.7B-2.5B
 
 
 
 
 
Other Liabilities2.0B2.0B1.8B1.9B
 
 
 
 
 
Total Liabilities56.7B55.7B51.9B49.1B
 
 
 
 
 
 
EquityMinority Interest---15.5M-200.5M-14.3M
 
 
 
 
Preferred Stock3.6B3.6B3.6B3.7B
 
 
 
 
 
Common Equity24.4B25.0B13.7B14.9B
 
 
 
 
 
Total Shareholder Equity28.0B28.6B17.4B18.6B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding1.0B1.0B1.0B1.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.